Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages
B W Jones, K A Heldwein, T K Means, J J Saukkonen, and M J Fenton
Ann Rheum Dis 2001; 60 (Supplement 3
): 6. doi:10.1136/ard.60.90003.iii6
[Abstract]
[Full text]
[PDF]
[Request Permissions]
High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach
B M J Foxwell, S Yoshimura, J Bondeson, F M Brennan, and M Feldmann
Ann Rheum Dis 2001; 60 (Supplement 3
): 13. doi:10.1136/ard.60.90003.iii13
[Abstract]
[Full text]
[PDF]
[Request Permissions]
Novel targets for interleukin 18 binding protein
C A Dinarello
Ann Rheum Dis 2001; 60 (Supplement 3
): 18. doi:10.1136/ard.60.90003.iii18
[Abstract]
[Full text]
[PDF]
[Request Permissions]
Biology of TACE inhibition
R C Newton, K A Solomon, M B Covington, C P Decicco, P J Haley, S M Friedman, and K Vaddi
Ann Rheum Dis 2001; 60 (Supplement 3
): 25. doi:10.1136/ard.60.90003.iii25
[Abstract]
[Full text]
[PDF]
[Request Permissions]
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor
F Van den Bosch, D Baeten, E Kruithof, F De Keyser, H Mielants, and E M Veys
Ann Rheum Dis 2001; 60 (Supplement 3
): 33. doi:10.1136/ard.60.90003.iii33
[Extract]
[Full text]
[PDF]
[Request Permissions]
Cytokine blockers in psoriatic arthritis
P J Mease
Ann Rheum Dis 2001; 60 (Supplement 3
): 37. doi:10.1136/ard.60.90003.iii37
[Abstract]
[Full text]
[PDF]
[Request Permissions]
Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines
P Greenberg
Ann Rheum Dis 2001; 60 (Supplement 3
): 41. doi:10.1136/ard.60.90003.iii41
[Extract]
[Full text]
[PDF]
[Request Permissions]
Role of cytokines in the innate immune response to intracellular pathogens
S Stenger and M Röllinghoff
Ann Rheum Dis 2001; 60 (Supplement 3
): 43. doi:10.1136/ard.60.90003.iii43
[Extract]
[Full text]
[PDF]
[Request Permissions]
Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment?
D van der Heijde
Ann Rheum Dis 2001; 60 (Supplement 3
): 47. doi:10.1136/ard.60.90003.iii47
[Abstract]
[Full text]
[PDF]
[Request Permissions]
"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate
M C Hochberg, J K Tracy, and R H Flores
Ann Rheum Dis 2001; 60 (Supplement 3
): 51. doi:10.1136/ard.60.90003.iii51
[Extract]
[Full text]
[PDF]
[Request Permissions]
Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences
H G Kraetsch, C Antoni, J R Kalden, and B Manger
Ann Rheum Dis 2001; 60 (Supplement 3
): 55. doi:10.1136/ard.60.90003.iii55
[Abstract]
[Full text]
[PDF]
[Request Permissions]
New treatment options in ankylosing spondylitis: a role for anti-TNF therapy
J Sieper and J Braun
Ann Rheum Dis 2001; 60 (Supplement 3
): 58. doi:10.1136/ard.60.90003.iii58
[Extract]
[Full text]
[PDF]
[Request Permissions]
Matrix metalloproteinase inhibitors in rheumatic diseases
D R Close
Ann Rheum Dis 2001; 60 (Supplement 3
): 62. doi:10.1136/ard.60.90003.iii62
[Abstract]
[Full text]
[PDF]
[Request Permissions]
The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages
A K Kiemer and A M Vollmar
Ann Rheum Dis 2001; 60 (Supplement 3
): 68. doi:10.1136/ard.60.90003.iii68
[Abstract]
[Full text]
[PDF]
[Request Permissions]
Antagonising angiogenesis in rheumatoid arthritis
P E C Brenchley
Ann Rheum Dis 2001; 60 (Supplement 3
): 71. doi:10.1136/ard.60.90003.iii71
[Extract]
[Full text]
[PDF]
[Request Permissions]
Oncostatin M in the anti-inflammatory response
A F Wahl and P M Wallace
Ann Rheum Dis 2001; 60 (Supplement 3
): 75. doi:10.1136/ard.60.90003.iii75
[Abstract]
[Full text]
[PDF]
[Request Permissions]
Osteoprotegerin
U Feige
Ann Rheum Dis 2001; 60 (Supplement 3
): 81. doi:10.1136/ard.60.90003.iii81
[Extract]
[Full text]
[PDF]
[Request Permissions]